aav2/8-hlp-fviii-v3
Gene therapyexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 14, 2017 (NCT03001830)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Coagulation factor VIIISupplementation
F8 supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- aav2/8-hlp-fviii-v3
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03001830 | Phase 1 | Jun 14, 2017 | Medical Research Council, University of London |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Medical Research Council | Government | 1 | 0 | 1 | 2017 |
| University of London | Academic/Hospital | 1 | 1 | 1 | 2017 |
2 organizations
Page 1 / 1